News

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...
(Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug ...